Home › Funds › Point72 Asset Management › DNLI
Point72 Asset Management position in DNLI
DENALI THERAPEUTICS INC · Health Care
Latest position (Q2 2026)46.40K sh
Reported value held$1.19M
Portfolio Weight0.00%
First reportedQ3 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 633.00K | $19.43M | New |
| Q4 2022 | 64.40K | $1.79M | Reduce |
| Q2 2023 | 223.47K | $6.59M | New |
| Q4 2023 | 644.41K | $13.83M | New |
| Q2 2024 | 1.05M | $24.45M | New |
| Q3 2024 | 333.53K | $9.72M | Reduce |
| Q4 2024 | 548.74K | $11.18M | Add |
| Q2 2025 | 2.21M | $30.97M | New |
| Q3 2025 | 2.52M | $36.58M | Add |
| Q4 2025 | 1.70M | $28.07M | Reduce |
| Q1 2026 | 45.20K | $867.84K | Reduce |
| Q2 2026 | 46.40K | $1.19M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNLI
- BlackRock Inc 14.03M sh · $360.76M · Q2 2026
- Baillie Gifford & Co 11.96M sh · $307.62M · Q2 2026
- Vanguard Group 13.06M sh · $215.59M · Q4 2025
- Temasek Holdings 7.01M sh · $180.37M · Q2 2026
- Fidelity Management & Research (FMR) 4.54M sh · $116.66M · Q2 2026
- Goldman Sachs Group 4.16M sh · $106.89M · Q2 2026
- Geode Capital Management 3.97M sh · $102.21M · Q2 2026
- UBS Group AG 3.12M sh · $80.26M · Q2 2026
- Norges Bank Investment Management 2.82M sh · $72.65M · Q2 2026
- Capital Research Global Investors 2.57M sh · $65.99M · Q2 2026
- Casdin Capital 2.04M sh · $52.60M · Q2 2026
- Principal Global Investors 1.42M sh · $36.52M · Q2 2026